Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Asthma × Etanercept × Clear all

Phase

Status

Sponsor Class

OTHER 1 NIH 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Psoriasis 3 Lymphoma, Follicular 3 Arthritis, Rheumatoid 3 Pruritus 1 Prostatic Neoplasms 1 Plaque, Amyloid 1 Bronchiolitis Obliterans Syndrome 1 Bites and Stings 1 Asthma 1 Arthritis, Juvenile 1

Interventions

Fluticasone-Salmeterol Drug Combination 3 Fluticasone 2 laninamivir 1 fluticasone-formoterol 1 NVP-QAV680 1 Formoterol Fumarate 1 Etanercept 1 Drug Delivery Systems 1 CS 8958 1 Budesonide, Formoterol Fumarate Drug Combination 1 Budesonide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00141791 2009-08-07

Study Evaluating Etanercept in Moderate to Severe Asthma

Wyeth is now a wholly owned subsidiary of Pfizer

Phase 2 Completed

Asthma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡